Parkinson's Disease Drug Market Report

Europe Parkinson's Disease Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 04, 2020
  • PAGES：136
  • REPORT CODE：GMM536173
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Parkinson's Disease Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Parkinson's Disease Drug Market Segmentations:

    By Player:

    • Stada Arzneimittel

    • Apokyn

    • Akorn

    • Desitin Arzneimittel

    • GSK

    • US WorldMeds

    • Endo Pharmaceuticals

    • Teva Pharmaceutical

    • Abbvie

    • Kyowa Hakko Kirin Pharma

    • Valeant Pharmaceuticals

    • Valeant

    • Novartis

    • Merck

    • Orion

    • Astellas Pharma

    • Valeant Pharmaceuticals

    By Type:

    • Sinemet-CR

    • Trastal

    • Madopar

    • COMT Inhibitor

    • Others

    By End-User:

    • Under 40 Years Old

    • 40-65 Years Old

    • Above 65 Years Old

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Parkinson's Disease Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Parkinson's Disease Drug Market Size and Growth Rate of Sinemet-CR from 2014 to 2026

    • 1.3.2 Europe Parkinson's Disease Drug Market Size and Growth Rate of Trastal from 2014 to 2026

    • 1.3.3 Europe Parkinson's Disease Drug Market Size and Growth Rate of Madopar from 2014 to 2026

    • 1.3.4 Europe Parkinson's Disease Drug Market Size and Growth Rate of COMT Inhibitor from 2014 to 2026

    • 1.3.5 Europe Parkinson's Disease Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Parkinson's Disease Drug Market Size and Growth Rate of Under 40 Years Old from 2014 to 2026

    • 1.4.2 Europe Parkinson's Disease Drug Market Size and Growth Rate of 40-65 Years Old from 2014 to 2026

    • 1.4.3 Europe Parkinson's Disease Drug Market Size and Growth Rate of Above 65 Years Old from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Parkinson's Disease Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Parkinson's Disease Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Sinemet-CR

      • 3.4.2 Market Size and Growth Rate of Trastal

      • 3.4.3 Market Size and Growth Rate of Madopar

      • 3.4.4 Market Size and Growth Rate of COMT Inhibitor

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Parkinson's Disease Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Parkinson's Disease Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Under 40 Years Old for Construction

      • 4.4.2 Market Size and Growth Rate of 40-65 Years Old for Construction

      • 4.4.3 Market Size and Growth Rate of Above 65 Years Old for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Parkinson's Disease Drug Production Analysis by Top Regions

    • 5.2 Europe Parkinson's Disease Drug Consumption Analysis by Top Regions

    • 5.3 Europe Parkinson's Disease Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Parkinson's Disease Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Parkinson's Disease Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Parkinson's Disease Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Parkinson's Disease Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Parkinson's Disease Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Parkinson's Disease Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Parkinson's Disease Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Parkinson's Disease Drug Landscape Analysis

    • 7.1 Germany Parkinson's Disease Drug Landscape Analysis by Major Types

    • 7.2 Germany Parkinson's Disease Drug Landscape Analysis by Major End-Users

    8. UK Parkinson's Disease Drug Landscape Analysis

    • 8.1 UK Parkinson's Disease Drug Landscape Analysis by Major Types

    • 8.2 UK Parkinson's Disease Drug Landscape Analysis by Major End-Users

    9. France Parkinson's Disease Drug Landscape Analysis

    • 9.1 France Parkinson's Disease Drug Landscape Analysis by Major Types

    • 9.2 France Parkinson's Disease Drug Landscape Analysis by Major End-Users

    10. Italy Parkinson's Disease Drug Landscape Analysis

    • 10.1 Italy Parkinson's Disease Drug Landscape Analysis by Major Types

    • 10.2 Italy Parkinson's Disease Drug Landscape Analysis by Major End-Users

    11. Spain Parkinson's Disease Drug Landscape Analysis

    • 11.1 Spain Parkinson's Disease Drug Landscape Analysis by Major Types

    • 11.2 Spain Parkinson's Disease Drug Landscape Analysis by Major End-Users

    12. Poland Parkinson's Disease Drug Landscape Analysis

    • 12.1 Poland Parkinson's Disease Drug Landscape Analysis by Major Types

    • 12.2 Poland Parkinson's Disease Drug Landscape Analysis by Major End-Users

    13. Russia Parkinson's Disease Drug Landscape Analysis

    • 13.1 Russia Parkinson's Disease Drug Landscape Analysis by Major Types

    • 13.2 Russia Parkinson's Disease Drug Landscape Analysis by Major End-Users

    14. Switzerland Parkinson's Disease Drug Landscape Analysis

    • 14.1 Switzerland Parkinson's Disease Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Parkinson's Disease Drug Landscape Analysis by Major End-Users

    15. Turkey Parkinson's Disease Drug Landscape Analysis

    • 15.1 Turkey Parkinson's Disease Drug Landscape Analysis by Major Types

    • 15.2 Turkey Parkinson's Disease Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Parkinson's Disease Drug Market Volume and Growth Rate

      • 16.3.2 Finland Parkinson's Disease Drug Market Volume and Growth Rate

      • 16.3.3 Norway Parkinson's Disease Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Parkinson's Disease Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Parkinson's Disease Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Parkinson's Disease Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Parkinson's Disease Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Parkinson's Disease Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Parkinson's Disease Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Parkinson's Disease Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Parkinson's Disease Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Stada Arzneimittel

      • 19.1.1 Stada Arzneimittel Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Apokyn

      • 19.2.1 Apokyn Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Akorn

      • 19.3.1 Akorn Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Desitin Arzneimittel

      • 19.4.1 Desitin Arzneimittel Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 GSK

      • 19.5.1 GSK Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 US WorldMeds

      • 19.6.1 US WorldMeds Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Endo Pharmaceuticals

      • 19.7.1 Endo Pharmaceuticals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Teva Pharmaceutical

      • 19.8.1 Teva Pharmaceutical Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Abbvie

      • 19.9.1 Abbvie Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Kyowa Hakko Kirin Pharma

      • 19.10.1 Kyowa Hakko Kirin Pharma Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Valeant Pharmaceuticals

      • 19.11.1 Valeant Pharmaceuticals Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Valeant

      • 19.12.1 Valeant Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Novartis

      • 19.13.1 Novartis Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Merck

      • 19.14.1 Merck Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Orion

      • 19.15.1 Orion Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Astellas Pharma

      • 19.16.1 Astellas Pharma Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Valeant Pharmaceuticals

      • 19.17.1 Valeant Pharmaceuticals Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    The List of Tables and Figures (Totals 79 Figures and 138 Tables)

    • Figure Product Picture

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Sinemet-CR Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Trastal Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Madopar Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of COMT Inhibitor Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Under 40 Years Old from 2014 to 2026

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of 40-65 Years Old from 2014 to 2026

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Above 65 Years Old from 2014 to 2026

    • Figure Germany Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Parkinson's Disease Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Parkinson's Disease Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Parkinson's Disease Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Parkinson's Disease Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Parkinson's Disease Drug by Different Types from 2014 to 2026

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Sinemet-CR Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Trastal Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Madopar Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of COMT Inhibitor Market, 2015 - 2026 (USD Million)

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Parkinson's Disease Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Parkinson's Disease Drug by Different End-Users from 2014 to 2026

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Under 40 Years Old from 2014 to 2026

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of 40-65 Years Old from 2014 to 2026

    • Figure Parkinson's Disease Drug Market Size and Growth Rate of Above 65 Years Old from 2014 to 2026

    • Table Europe Parkinson's Disease Drug Production by Major Regions

    • Table Europe Parkinson's Disease Drug Production Share by Major Regions

    • Figure Europe Parkinson's Disease Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Parkinson's Disease Drug Consumption by Major Regions

    • Table Europe Parkinson's Disease Drug Consumption Share by Major Regions

    • Table Germany Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table UK Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table France Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Italy Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Spain Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Poland Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Russia Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Parkinson's Disease Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Parkinson's Disease Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Parkinson's Disease Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Parkinson's Disease Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Germany Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table UK Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table UK Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table UK Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table France Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table France Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table France Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Italy Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Spain Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Poland Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Russia Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Turkey Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Parkinson's Disease Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Parkinson's Disease Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Parkinson's Disease Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Parkinson's Disease Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Stada Arzneimittel Profiles

    • Table Stada Arzneimittel Production, Value, Price, Gross Margin 2014-2019

    • Table Stada Arzneimittel Product benchmarking

    • Table Stada Arzneimittel Strategic initiatives

    • Table Stada Arzneimittel SWOT analysis

    • Table Apokyn Profiles

    • Table Apokyn Production, Value, Price, Gross Margin 2014-2019

    • Table Apokyn Product benchmarking

    • Table Apokyn Strategic initiatives

    • Table Apokyn SWOT analysis

    • Table Akorn Profiles

    • Table Akorn Production, Value, Price, Gross Margin 2014-2019

    • Table Akorn Product benchmarking

    • Table Akorn Strategic initiatives

    • Table Akorn SWOT analysis

    • Table Desitin Arzneimittel Profiles

    • Table Desitin Arzneimittel Production, Value, Price, Gross Margin 2014-2019

    • Table Desitin Arzneimittel Product benchmarking

    • Table Desitin Arzneimittel Strategic initiatives

    • Table Desitin Arzneimittel SWOT analysis

    • Table GSK Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table GSK Product benchmarking

    • Table GSK Strategic initiatives

    • Table GSK SWOT analysis

    • Table US WorldMeds Profiles

    • Table US WorldMeds Production, Value, Price, Gross Margin 2014-2019

    • Table US WorldMeds Product benchmarking

    • Table US WorldMeds Strategic initiatives

    • Table US WorldMeds SWOT analysis

    • Table Endo Pharmaceuticals Profiles

    • Table Endo Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Endo Pharmaceuticals Product benchmarking

    • Table Endo Pharmaceuticals Strategic initiatives

    • Table Endo Pharmaceuticals SWOT analysis

    • Table Teva Pharmaceutical Profiles

    • Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Teva Pharmaceutical Product benchmarking

    • Table Teva Pharmaceutical Strategic initiatives

    • Table Teva Pharmaceutical SWOT analysis

    • Table Abbvie Profiles

    • Table Abbvie Production, Value, Price, Gross Margin 2014-2019

    • Table Abbvie Product benchmarking

    • Table Abbvie Strategic initiatives

    • Table Abbvie SWOT analysis

    • Table Kyowa Hakko Kirin Pharma Profiles

    • Table Kyowa Hakko Kirin Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Kyowa Hakko Kirin Pharma Product benchmarking

    • Table Kyowa Hakko Kirin Pharma Strategic initiatives

    • Table Kyowa Hakko Kirin Pharma SWOT analysis

    • Table Valeant Pharmaceuticals Profiles

    • Table Valeant Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Valeant Pharmaceuticals Product benchmarking

    • Table Valeant Pharmaceuticals Strategic initiatives

    • Table Valeant Pharmaceuticals SWOT analysis

    • Table Valeant Profiles

    • Table Valeant Production, Value, Price, Gross Margin 2014-2019

    • Table Valeant Product benchmarking

    • Table Valeant Strategic initiatives

    • Table Valeant SWOT analysis

    • Table Novartis Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis Product benchmarking

    • Table Novartis Strategic initiatives

    • Table Novartis SWOT analysis

    • Table Merck Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Merck Product benchmarking

    • Table Merck Strategic initiatives

    • Table Merck SWOT analysis

    • Table Orion Profiles

    • Table Orion Production, Value, Price, Gross Margin 2014-2019

    • Table Orion Product benchmarking

    • Table Orion Strategic initiatives

    • Table Orion SWOT analysis

    • Table Astellas Pharma Profiles

    • Table Astellas Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Astellas Pharma Product benchmarking

    • Table Astellas Pharma Strategic initiatives

    • Table Astellas Pharma SWOT analysis

    • Table Valeant Pharmaceuticals Profiles

    • Table Valeant Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Valeant Pharmaceuticals Product benchmarking

    • Table Valeant Pharmaceuticals Strategic initiatives

    • Table Valeant Pharmaceuticals SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US